Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1 study found for:    NCT01540253
Show Display Options
Rank Status Study
1 Completed PI3K Inhibitor BKM120 and Docetaxel in Treating Patients With Advanced Solid Tumor That is Locally Advanced, Cannot Be Removed By Surgery, or Metastatic
Condition: Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: PI3K inhibitor BKM120;   Drug: docetaxel;   Other: pharmacological study;   Other: questionnaire administration;   Other: laboratory biomarker analysis

Study has passed its completion date and status has not been verified in more than two years.